FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

377544003: Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2529262017 Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2532641019 Neomycin sulfate+polymyxin b sulfate+prednisolone acetate 0.35%/10000unt/0.5%wv suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3084832018 Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3269951000052114 neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension sv Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Is a Product containing neomycin (medicinal product) false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Is a Compound neomycin preparations false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Is a neomycin för lokalt bruk false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Is a Product containing polymyxin B (medicinal product) false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient Polymyxin B (substance) false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient Topical neomycin false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Is a neomycinsulfat + polymyxin B-sulfat + prednisolonacetat false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient Prednisolone acetate false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient Polymyxin B sulfate (substance) false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient Corticosterone false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient antiinfektivt medel för huden false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient Neomycin sulfate false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient binjurehormonmedel false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient Local anti-infective false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient Glucocorticoid hormone false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has active ingredient Bactericide false Inferred relationship Some
    neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start